Advise  ·  Transform  ·  Invest
Turning Industry Insight into Resilient Value Creation
Dr. Paul Geymayer
Advisor Board Member Interim Leader Investor
Dr. Paul Geymayer
25+ years building businesses across three continents
Senior operating leadership in Europe, Asia Pacific and MENA — across public, PE-backed and family-owned environments, in all major market archetypes of the off-patent medicines industry.
P&L responsibility up to €900 million and 2,700 people
Delivered profitable growth, operational improvement and strong cash generation at Zentiva, Sandoz, MS Pharma and ratiopharm — consistently, across different ownership models and market conditions.
Doctorate in organic chemistry and biochemistry
A genuine scientific foundation that sharpens analytical rigour and credibility in technically complex markets — bridging scientific depth with commercial strategy in a way few senior executives can.
Transformation across the full complexity spectrum
Carve-outs, turnarounds, market entries, M&A integrations and full-potential programmes — always with speed as the differentiator. 25+ years of pattern recognition translates directly into faster decisions and measurable results.
Multiple affiliate board memberships
Contributed to strategic oversight, governance and leadership development across international pharmaceutical organisations — providing perspective that bridges operational reality with board-level expectations.
Open to advisory, board and co-investment mandates
Working with PE investors, boards and management teams as advisor, board member and investor. Available for selective interim executive assignments where decisive, hands-on leadership can accelerate transformation and value creation.
Advise

Strategic guidance to investors, boards and management teams in the off-patent medicines sector — drawing on deep industry experience and an international leadership background spanning market archetypes, portfolio strategy, pricing and commercial excellence.

 

More ↗
Transform

Operational leadership and performance improvement in complex pharmaceutical organisations — bringing structure, clarity and decisiveness to align people, strategy and delivery. Available for select interim executive mandates where decisive, hands-on leadership accelerates results.

More ↗
Invest

Open to co-investing alongside private equity partners and entrepreneurs in portfolio companies and board mandates — actively contributing to value creation through strategic guidance, operational expertise and hands-on leadership support that goes beyond a purely financial commitment.

More ↗

Industry depth meets speed to act.

A career at the intersection of scientific understanding, commercial strategy and operational leadership. A scientific mindset drives structured thinking, curiosity and analytical depth — executive experience ensures pragmatic decisions, speed and execution.

The differentiator is combining industry knowledge and a proven operational track record with speed. With 25+ years of pattern recognition, moving quickly from analysis to action and from strategy to measurable results — across carve-outs, turnarounds, market entries, M&A integrations and full-potential transformations.

Dr. Paul Geymayer
Data-Driven & AI-Enhanced

Using analytics and increasingly AI-supported insight to guide portfolio priorities, pricing strategies and strategic resource allocation — turning data into decisive action.

Transformation Leadership

Bringing structure, clarity and decisiveness to business transformation — aligning people, strategy and execution to unlock performance across multiple geographies and ownership models.

Industry Value Creation

Fluent in the core value creation levers of off-patent medicines — portfolio optimisation, pricing discipline, commercial excellence, geographic footprint and organisational effectiveness.

Clarity of direction.
Respect for people.
Respect for facts.

I believe effective leadership combines clarity of direction with genuine respect for people and facts — valuing insight over rhetoric and decisions over deliberation. I aim to create environments where teams perform at their best and where execution is never an afterthought.

Accountability, respect, trust and empowerment are the pillars of my leadership approach — built on decades of leading international teams across multiple cultures, ownership structures and business cycles.

Outside the boardroom, I am an ultra-trail runner. The preparation, resilience and ability to navigate complex terrain over long distances is not incidental to how I lead — it reflects it.

Decisive under pressure.
Disciplined in execution.
Long-term in perspective.

Nach oben scrollen